Champions Oncology (CSBR) Total Current Liabilities (2011 - 2026)

Champions Oncology's Total Current Liabilities history runs 16 years deep, the most recent figure standing at $20.7 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 4.06% year-over-year to $20.7 million; the TTM figure through Jan 2026 stood at $20.7 million (up 4.06% YoY), while the FY2025 annual figure was $23.9 million, up 10.73% from the prior year.
• Total Current Liabilities was $20.7 million for Q1 2026 at Champions Oncology, down from $22.1 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $23.9 million in Q2 2025 to a low of $15.5 million in Q1 2022.
• Historically, Total Current Liabilities has averaged $20.2 million across 5 years, with a median of $20.7 million in 2026.
• The sharpest annual moves came in 2022 and 2024: Total Current Liabilities jumped 56.08% in 2022, then decreased 9.97% in 2024.
• A 5-year view of Total Current Liabilities shows it stood at $18.7 million in 2022, then advanced by 11.82% to $21.0 million in 2023, then slipped by 9.97% to $18.9 million in 2024, then increased by 17.39% to $22.1 million in 2025, then decreased by 6.61% to $20.7 million in 2026.
• The last three Total Current Liabilities figures came in at $20.7 million (Q1 2026), $22.1 million (Q4 2025), and $22.7 million (Q3 2025), per Business Quant data.